Oncology Institute Inc - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE

Ticker Exchange SIC # Website Latest Ticker
TOI Nasdaq 8011 https://theoncologyinstitute.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Oncology Institute Inc

The Oncology Institute Expands Into Chino, CA - Dec 19th, 2022 1:00 pm
The Oncology Institute Rebrands Clinical Trials Division - Dec 15th, 2022 1:00 pm
The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa - Nov 22nd, 2022 1:00 pm
The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance - Nov 9th, 2022 9:05 pm
The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference - Nov 1st, 2022 12:00 pm
The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call - Oct 19th, 2022 12:00 pm
The Oncology Institute Executives to Speak at Key Industry Conferences in Q4 - Oct 17th, 2022 8:05 pm
The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials - Oct 11th, 2022 12:00 pm
The Oncology Institute Expands into South Florida - Oct 6th, 2022 12:00 pm
The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib - Sep 29th, 2022 12:00 pm
The Oncology Institute Appoints Two New Board Members - Sep 22nd, 2022 8:05 pm
The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium - Sep 15th, 2022 12:00 pm
The Oncology Institute Becomes Certified as a Patient Safety Organization - Sep 12th, 2022 12:00 pm
The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms - Aug 22nd, 2022 12:00 pm
The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day - Aug 16th, 2022 12:00 pm
The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance - Aug 9th, 2022 8:06 pm
The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets - Aug 9th, 2022 8:05 pm
The Oncology Institute Continues its Nevada Expansion - Jul 26th, 2022 12:00 pm
The Oncology Institute Announces Second Quarter 2022 Earnings Release Date and Conference Call - Jul 19th, 2022 12:00 pm
The Oncology Institute Continues Southern California Expansion - Jul 7th, 2022 8:05 pm